Summary:
Hematopoietic stem cell transplantation (HSCT) is being increasingly utilized for the treatment of a whole spectrum of severe autoimmune diseases refractory to conventional therapy. Although allogeneic HSCT has been followed by durable complete remission in a restricted number of patients with coincidental disease, the autologous procedure is generally preferred because of its lesser toxicity. Most autoimmune diseases are the consequence of a multistep process, mainly originating from the interplay of genetic, environmental, and hormonal factors. It has been postulated that if immunosuppressive regimens can eliminate or effectively reduce the level of autoreactive T and B cells, then regeneration of de novo immunity even in the autologous setting may bypass the initial breakdown of self-tolerance and ensure prolonged disease remission. As mentioned in a recent review of this field, protocol design including conditioning regimen, patient selection, stem cell source and final outcome are likely to be disease-specific. The following is a summary of the 2002 International Bone Marrow Transplantation Registry/American Society of Blood and Bone Marrow Transplantation (IBMTR/ASBMT) satellite symposium in Orlando, Florida on 24 February 2002 on ‘Expanding the Promise of Hematopoietic Stem Cell Transplantation in Autoimmune Diseases’.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Marmont AM, van Lint MT, Gualandi F, Bacigalupo A . Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 1997; 6: 545–548.
Burt RK, Traynor A, Ramsey-Goldman R . Hematopoietic stem-cell transplantation for systemic lupus erythematosus. N Engl J Med 1997; 337: 1777–1778.
Traynor AE, Schroeder J, Rosa RM et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 2000; 356: 701–707.
Burt RK, Slavin S, Burns WH, Marmont A . Induction of tolerance in autoimmune disease by hematopoietic stem cell transplantation; getting closer to a cure? Blood 2002; 99: 870–887.
Farmer RG, Whelan G, Fazio VW . Long-term follow-up of patients with Crohn's disease. Relationship of the clinical pattern and prognosis. Gastroenterology 1985; 88: 1818–1827.
Best WR, Becktel JM, Singleton JW, Kern F . Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 843.
Steinman L . Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996; 85: 299–302.
Ferguson B, Matyszak MK, Esiri MM, Perry VH . Axonal damage in multiple sclerosis lesions. Brain 1997; 120: 393–399.
Trapp BD, Peterson J, Ransohoff RM et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278–285.
Burt RK, Padilla J, Begolka WS et al. Effect of disease stage on outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis. Blood 1998; 97: 2609–2616.
Burt RK, Traynor AE, Cohen B et al. T-cell depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant 1998; 21: 539–541.
Burt RK, Traynor AE, Pope R et al. Treatment of autoimmune diseases by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood 1998; 92: 3505–3514.
Burt RK, Cohen BA, Lobeck LJ et al. Immune suppressive therapy with autologous hematopoietic stem cell transplantation arrests active CNS inflammation but not axonal atrophy in patients with severe disability and progressive multiple sclerosis. Blood 2001; 98: p687a (abst 2871).
Openshaw H, Lund BT, Kashyap A et al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring. Biol Blood Marrow Transplant 2000; 3: 563–575.
Nash RA, Dansey R, Storek J et al. Epstein–Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) after high-dose immunosuppressive therapy (HDIT) and autologous CD34-selected stem cell transplantation (SCT) for severe autoimmune diseases [abstract]. Blood 2000; 96(Suppl.): 406a.
Oyama Y, Cohen B, Traynor AE et al. Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplant 2002; 9: 81–85.
Brodsky RA, Petri M, Smith BD et al. Immunablative high dose cyclophosphamide without stem cell rescue for refractory severe autoimmune disease. Ann Intern Med 1998; 129: 1031–1035.
van Bekkum DW . Stem cell transplantation in experimental models of autoimmune disease. J Clin Immunol 2000; 20: 10–16.
Tyndall A, Fassas A, Passweg J et al. Autologous haematopoietic stem cell transplants for autoimmune disease—feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease. Bone Marrow Transplant 1999; 24: 729–734.
Marmont AM . New horizons in the treatment of autoimmune diseases: immunoablation and stem cell transplantation. Ann Rev Med 2000; 51: 115–134.
Mancardi GL, Saccardi R, Filippi M et al. Italian GITMO-NEURO Intergroup on autologous hematopoietic stem cell transplantation for multiple sclerosis. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology 2001; 57: 62–68.
McColl G, Kohsaka H, Szer J, Wicks I . High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis. Ann Int Med 1999; 131: 507–509.
Zaydan MA, Turner C, Miller AM . Resolution of chronic idiopathic thrombocytopenia purpura following syngeneic peripheral blood progenitor transplant. Bone Marrow Transplant 2002; 29: 87–89.
Gratwohl A, Passweg J, Gerber I, Tyndall A . International stem cell project for autoimmune diseases. Stem cell transplantation for autoimmune diseases. Bailliere's Best Pract Clin Haematol 2001; 14: 755–776.
Slavin S, Nagler A, Varadi G, Or R . Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853–857.
Hinterberger W, Hinterberger-Fischer M, Marmont AM, Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcomes after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002; 30: 753–759.
Oyama Y, Papadopoulos EB, Miranda M et al. Allogeneic stem cell transplantation for Evans Syndrome. Bone Marrow Transplant 2001; 28: 903–905.
Marmont AM, Gualandi F, Bacigalupo A . Refractory Evan syndrome treated with allogeneic SCT followed by DLI. Demonstration of graft-versus-autoimmunity effect. Bone Marrow Transplant 2003; 31: (in press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Burt, R., Traynor, A., Craig, R. et al. The promise of hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 31, 521–524 (2003). https://doi.org/10.1038/sj.bmt.1703868
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703868
This article is cited by
-
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study
Leukemia (2008)
-
Synergistic effects of injection of bone marrow cells into both portal vein and bone marrow on tolerance induction in transplantation of allogeneic pancreatic islets
Bone Marrow Transplantation (2006)
-
Treatment of severe autoimmune disease by stem-cell transplantation
Nature (2005)
-
Ovarian tissue cryopreservation: benefits and risks
Cell and Tissue Research (2005)
-
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease
Bone Marrow Transplantation (2004)